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Summary
Background: Epidermal growth factor (EGF) receptor ligands (EGFRL) including transforming growth fac-
tor alpha (TGF-α), amphiregulin, and heparin binding – EGF (HB-EGF) are involved in gas-
tric mucosal repair in chronic gastritis. Their mRNA expression has been shown to be upreg-
ulated after Helicobacter pylori (H.p.)-eradication but little is known about this gene expression
in atrophic gastritis. The purpose of our study was to investigate EGFRL mRNA expression in
gastric mucosa of patients with atrophic gastritis before and after H.p.-eradication.
Material/Methods: Antral mucosal biopsies were obtained during endoscopy in 10 H.p. positive patients with
atrophic gastritis and in 10 H.p. negative controls with intact mucosa. Total RNA of antral
biopsies was extracted and RT-PCR was performed, the PCR-products being measured den-
sitometrically. Values were compared with mRNA expressions in H.p. negative antral mucosa
(n=10).
Results: Gastric biopsies revealed mRNA expression for TGF-α, amphiregulin and HB-EGF, both in
H.p. positive atrophic antritis and in H.p. negative healthy mucosa. The mRNA expression of
TGF-α in atrophic gastritis was significantly upregulated after H.p.-eradication, whereas that
of amphiregulin did not change after this eradication. Expression of HB-EGF mRNA was
higher in H.p.-infection than after H.p.-eradication or in H.p. negative healthy subjects.
Conclusions: H.p. positive atrophic gastritis is associated with differential mRNA expression of EGF recep-
tor ligands. H.p.-eradication in this entity leads to unequal changes of these growth factor
expressions compared to chronic active gastritis without atrophy.
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BACKGROUND
Helicobacter pylori (H.p.) causes chronic active inflamma-
tion of the gastric mucosa in the majority of infected
patients. Over long time it favors the loss of gastric
glands with development of atrophic gastritis in up to
84% of patients [1]. This may be associated with the
occurrence of intestinal metaplasia and increased risk
for gastric cancer [2]. Various mechanisms for the
pathogenesis of gastric cancer are discussed, including
inflammation-related cascades of cytokines generation
of reactive oxygen species (ROS), up- or downregula-
tion of certain growth factors and their receptors, and
the fundic atrophy-related impairment of acid output
and reduced intraluminal acidity [3].
One of the growth factors, which are involved in epithe-
lial cell proliferation and differentiation of the gastric
mucosa, is the epidermal growth factor (EGF) [4,5],
which binds to a specific cell receptor (EGF-R) [6].
Meanwhile, other EGF-homologous peptides (e.g. trans-
forming growth factor-α – TGFα, amphiregulin and
heparin-binding EGF – HB-EGF) have been detected.
Some of them have been shown to be expressed in nor-
mal and cancerous gastric mucosa [7-11]. There are
hints to suppose an association between EGF ligands
(EGFRL) expression and H.p. infection [12]. Previously,
we revealed that expressions of EGF receptor and
mRNA of TGF-α, amphiregulin and HB-EGF are
decreased in H.p. induced chronic active gastritis and
that they are upregulated after successful eradication
therapy [13].
The aim of our study was to evaluate whether similar
changes of gene expressions of these growth factors are
detectable in H.p. positive atrophic gastritis before and
after H.p. eradication and to compare growth factor
expression in atrophic gastritis with these in healthy
H.p. negative intact gastric mucosa.
MATERIAL AND METHODS
Patients
10 patients with histologically proven atrophic gastritis
and 10 healthy subjects with normal mucosa were endo-
scopically examined and biopsies were taken from the
antral mucosa. H.p. status was confirmed by rapid ure-
ase test (CLO). The biopsies were immediately frozen at
–80°C with liquid nitrogen until further processing for
RNA extraction. In H.p. positive patients the endoscopi-
cal re-evaluation with CLO test was performed 8 weeks
after successful 1-week standard anti-H.p. eradication
therapy with omeprazol (20 mg/bd), clarithromycin (250
mg/bd) and amoxicillin (500 mg/td).
The study was approved by the Local Ethical Commit-
tee of Münster University and informed consent was
obtained from all patients.
RNA extraction and DNA digestion
After tissue homogenisation by ultrasound (Labsonic
1510, Braun, Melsungen, Germany) total RNA was
extracted with the acid guanidinium thiocyanate phenol
method as described before (14). The RNA pellet was
air dried and resuspended in HPLC grade water (18
mega Ohm resistance). RNA concentration was deter-
mined spectrophotometrically at 260 nm. To avoid
DNA contamination RNA template was incubated with 1
U RNAase free DNAase (Promega/Serva, Heidelberg,
Germany) in a buffer containing 50 mM Tris-HCl, pH
7.5, 1 mM MgCl2, 1 mg/ml BSA at 37°C for 15 min.
Before further processing DNAase was heat inactivated
at 95°C for 2 min.
Semiquantitative RT-PCR
3 µg RNA was subjected to RT-PCR for 1 h at 37°C
using 20 U MuLV Reverse Transcriptase (Boehringer
Mannheim, Germany) in a 5-fold buffer supplied with
the enzyme (250 mM Tris-HCl, 200 mM KCl, 30 mM
MgCl2, 50 mM dithioerythriol, pH 8.3). The final con-
centration of desoxy-nucleotide triphosphates (dNTP-
Mix, Promega/Serva) was 1 mM.
20 U of ribonuclease inhibitor (RNAsin, Promega/Serva)
and 100 pmol random primer (Boehringer Mannheim,
Germany) were added to yield a final volume of 20 µl.
All substances were pipetted on ice. The cDNA obtained
by reverse transcription (RT) was amplified by PCR
using the following primer pairs selected with the com-
puter program Oligo 5.0 (NBI Inc, Annapolis, MN,
U.S.A.) and commercially synthesized and purified by
HPLC (Biometra, Göttingen, Germany). Annealing tem-
peratures and length of the PCR products are shown in
parenthesis:
1. TGF-α
5’-Primer: 5’ CGC CCT GTT CGC TCT GGG TAT
3’-Primer: 5’ AGG AGG TCC GCA TGC TCA CAG
(55°C, 264 bp)
2. Amphiregulin
5’-Primer: 5’ AGT CAG AGT TGA ACA GGT AGT TAA G
3’-Primer: 5’ ACT GTA ATA ACA GCA ACA GCT GTG A
(53°C, 360 bp)
3. HB-EGF
5’-Primer: 5’AAA AGA AAG AAG AAA GGC AA
3’-Primer: 5’CTC CTA TGG TAC CTA AAC AT
(55°C, 290 bp)
Additionally as internal standard for RNA quality and
quantity we used the pyruvate dehydrogenase sequence
(PDH), an unregulated housekeeping gene [15]. Like
most of the primers for EGFRL primers for PDH were
placed on two different exons. The sequences of the
PDH primers were:
5’-Primer: 5’GGT ATG GAT GAG GAC CTG GA
3’-Primer: 5’CTT CCA CAG CCC TCG ACT AA
(62°C, 105 bp)
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These primers yielded a DNA signal at approximately
240 bp thereby conveniently allowing to monitor DNA
contamination. The DNAase treatment effectively elimi-
nated amplification of DNA, which might interfere with
the quantitation of mRNA. PCR was performed in a
thermocycler (Gene Ataq Controller, Pharmacia, Upp-
sala, Sweden). For all EGFRL optimal PCR conditions
such as annealing temperatures as well as primer – and
– MgCl2-concentrations were established in pilot experi-
ments and followed the procedures as described [13,16].
The denaturation step was performed at 95°C for 45
sec, annealing time was 1 min and primer extension was
carried out at 72°C for 1 min. For amplification of the
desired cDNA we used 2.5 U of Taq DNA polymerase
(Gibco BRL, Gaithersburg, MD, U.S.A.) in 10 µl of 10-
fold buffer supplied with the enzyme (20 mM Tris-HCl,
50 mM KCl, pH 8.4) to which 2 µl of 10 mM dNTP-Mix
(Promega/Serva), MgCl2 to a final concentration of 2
mM and 30 pmol of primers were added to yield a final
volume of 100 µl.
To compare RNA expression of gastric biopsies before
and after eradication therapy we performed a modified
semiquantitative PCR analysis [17] in which for all
primer pairs, including the housekeeping gene, the
amount of PCR products was determined in 3-cycle
intervals starting from cycle 24. PCR products were sub-
jected to agarose gel electrophoresis with 1.5% agarose
in Tris-acetate-EDTA-buffer (Merck, Darmstadt, Ger-
many) as described [18]. Gels were stained with ethidi-
um bromide (0.5 µg/ml, Boehringer, Mannheim, Ger-
many), visualized on a UV-screen, photographed on
Polaroid and photographs were saved on disk. Band
intensities were measured by soft laser scanning densito-
metry and analysed with the computer program Image
Quant Version 4.2 (Molecular Dynamics, Sunnyvale,
CA, U.S.A.). Optical densities (ODI) were determined in
arbitrary units.
For each RNA sample and primer pair we obtained
PCR kinetics by correlating ODI’s with the cycle num-
ber. This enabled us to select one cycle for comparison
within the exponential phase of the curves. For each
RNA sample quantitative PCR was also performed with
the PDH primer pair. ODI of specific primer pairs were
quantitated relative to PDH kinetics leading to ODI-
ratios, which allowed us to compare different RNA sam-
ples. This technique has been extensively evaluated and
was found to have an interassay variation between 17 to
34% for the different primer pairs [16].
Identity of amplification products was verified by
restriction analysis. TGF-α and HB-EGF were incubated
with 3U BsuR I (MBI Fermentas, St. Leon-Rot, Ger-
many) in a buffer containing 10 mM Tris-HCl, 10 mM
MgCl2, 100 mM KCl, pH 8.5 while amphiregulin was
incubated with 3U Alu I (MBI Fermentas) in a buffer
containing 33 mM Tris-acetate, 10 mM Mg-acetate and
66 mM K-acetate, pH 7.9 for 30 min at 37°C. Restriction
fragments were separated by agarose gel electrophoresis
as described above [16].
Statistical analysis 
Data were statistically analysed with the paired Student
t-test. Differences with P<0.05 were considered as sig-
nificantly different.
RESULTS
The mRNA expression of TGF-α, amphiregulin and
HB-EGF was measured in optical density units and was
correlated with the cycle number (Fig. 1). Cycle 39 was
chosen for mRNA determination of EGFRL and cycle
33 for determination of PDH. Optical density units were
divided to obtain ODI ratios.
TGF-α and HB-EGF mRNA were found to be regularly
expressed in samples of normal gastric mucosa (100 and
90%, respectively) and atrophic gastric mucosa (90 and
100%, respectively), whereas the amphiregulin expres-
sion was only detected in 60% of normal gastric mucosa
and 40% of atrophic gastritis mucosa (Tab. 1).
To reveal expression of the EGFRL in a semiquantita-
tive manner, the appearance of the amplified DNA sig-
nals was assessed relative to that of the housekeeping
gene, PDH. Under our PCR conditions the amplifica-
tion efficiency of the primer pairs for EGFRL was simi-
lar to that of PDH.
TGF-α mRNA expression
TGF-α mRNA expression was reduced in H.p.-infected
atrophic gastritis (ODI ratio 0.12±0.06) but revealed
TGF-α
HB-EGF
Amphiregulin
Normal gastric
mucosa(n=10)
10 
9 
6
Atrophic gastritis
(n=10)
9 
10 
4 
Table 1. Occurrence of mRNA expression of EGFRL in normal and
atrophic gastritis
0
10
20
30
Cycle
O
D
I
TGF-alpha
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Figure 1. The mRNA expression of TGF-α, amphiregulin and HB-EGF
in the antral mucosa of a patient with H.p.-positive atrophic
gastritis. Data were correlated to the cycle number. Cycle 39
within the exponential phase of the curve was selected for
comparison of the mRNA levels.
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significantly higher expression levels after H.p.-eradica-
tion (ODI-ratio 2.52±4.7, p<0.01). The latter reached
approximately the mRNA expression observed in nor-
mal gastric mucosa (Fig. 2, 3a).
HB-EGF mRNA expression
The mRNA expression of HB-EGF was significantly
higher in H.p.-positive atrophic gastritis (ODI ratio
2.22±1.85, p<0.03, Fig. 2, 3b), when compared to H.p.-
negative normal mucosa (1.29±0.96). Following the
H.p. eradication the mRNA of HB-EGF tended to
increase but this increase did not reach statistical signifi-
cance.
Amphiregulin mRNA expression
The mRNA expression of amphiregulin was similar in
normal gastric mucosa (ODI ratio 1.03±1.04), H.p.-pos-
itive (ODI-ratio 0.87±1.13) and H.p.-negative (ODI-
ratio 0.74±1.20) atrophic gastritis and revealed no sig-
nificant differences between these three types of mucosa
(Fig. 2).
DISCUSSION
EGF and its homologous EGFRL bind to the EGF
receptor, stimulate autophosphorylation by the intrinsic
tyrosine activity of the receptor and induce intracellular
signal transduction [19,20]. Previous immunhistochemi-
cal studies detected local expression of these growth fac-
tors in the human gastric mucosa [13,21,22]. As they are
known to mediate angiogenesis [23] and stimulation of
fibroblasts and smooth muscle cells [24,25], it has been
suggested that they play an important role in regenera-
tive processes of the gastrointestinal tract.
Previously, we described that mRNA expression levels
of TGF-α, HB-EGF and amphiregulin are markedly
decreased in the H.p.-infected stomach and increased
significantly after successful H.p.-eradication to levels of
mRNA expression in normal gastric mucosa [13]. In this
connection antral mucosa revealed a more severe injury
by H.p. infection than the oxyntic mucosa. This remains
in agreement with recent study showing that H.p. eradi-
cation in duodenal ulcer patients results in normaliza-
tion of EGF and EGF receptor expression in gastric
mucosa after six weeks [26] or two years following eradi-
cation [27].
The aim of the study was to examine the mRNA expres-
sion of these growth factors in H.p. infected atrophic
gastric mucosa before and after eradication therapy and
to compare the data with the expression levels in nor-
mal gastric mucosa. The question is of special interest
since reduction or reversibility of atrophic gastritis was
described after eradication of H.p. [28] and since
expression of growth factors such as TGF-α, and hepa-
tocyte growth factor (HGF) may contribute to gastric
cancerogenesis [29] following atrophic gastritis and gas-
tric dysplasia.
TGF-α expression pattern in our patients with atrophic
gastritis was similar to that in H.p.-induced chronic
active gastritis without gastric atrophy [13]. It was
markedly reduced in H.p.-infection but increased after
successful eradication therapy. This finding again con-
firms the reports of other authors who also revealed a
marked reduction in mucosal cytokine levels signifying
enhanced mucosal inflammation, and increased EGF
levels after H.p. eradication [26,27,30].
The mRNA expression of amphiregulin was only detect-
ed in 40% of H.p. positive atrophic gastritis and did not
show significant changes after H.p. eradication. The low
occurrence and unchanged expression levels indepen-
dent on the H.p.-status may signify only slight influence
of this growth factor on the healing process of atrophic
gastritis.
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Figure 2. Levels of EGFRL mRNA expressions in normal, H.p.-infected
and H.p.-eradicated atrophic gastric mucosa (ODI ratios:
EGFRL/PDH). Asterisk indicates significant change as com-
pared to values recorded in H.p. negative intact mucosa.
Cross indicates significant change as compared to H.p.
infected atrophic gastritis.
Figure 3 a-c. EGFRL-RT-PCR products of two different RNA samples
of the same patient. Each RNA sample is represented on the
agarose gel by 6 lanes containing PCR products from cycle
numbers 30, 33, 36, 39, 42 and 45. Lanes 1-6 show the
band intensities of TGF-α, HB-EGF and amphiregulin in the
antral mucosa before, lanes 7-12 after eradication therapy.
A
B
C
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Interestingly, mRNA expression of HB-EGF was higher
in H.p. positive atrophic gastritis compared to normal
gastric mucosa and decreased after H.p. eradication.
This may hint a hyperregenerative activity, especially
for stimulation of fibroblasts, in acute H.p.-infection and
would agree with data of increased mucosal cell prolif-
eration in H.p.-infected gastric mucosa [31].
It is still a matter of debate if H.p.-eradication reverses
atrophy in chronic gastritis. Some authors revealed
improvement of all gastritis scores including atrophy
and lymphoid follicle score [32], whereas others cast
doubt on the reversibility of gastric atrophy [33].
Our data emphasize that local expression of regenera-
tive growth factors in the H.p.-positive atrophic gastritis
are partially changed due to successful eradication ther-
apy [34]. This may be associated with a possible
reversibility of gastric atrophy and should be further
examined in long-term follow-up studies.
CONCLUSIONS
This study shows that H.p. positive gastritis is associated
with a marked upregulation TGF-α, whereas expression
of mRNA for amphiregulin did not change and expres-
sion of HB-EGF was reduced after H.p. eradication as
compared to that before this therapy or that in H.p.
negative healthy subjects. We conclude that eradication
of H.p. in atrophic gastritis is associated with differential
mRNA expression of various EGFRL characterized by
enhanced expression of mRNA for TGF-α, no change in
expression for amphiregulin and reduced expression
for HB-EGF.
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